These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17284093)

  • 1. Pharmacological treatment of the psychosis of Alzheimer's disease: what is the best approach?
    Madhusoodanan S; Shah P; Brenner R; Gupta S
    CNS Drugs; 2007; 21(2):101-15. PubMed ID: 17284093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of psychosis in patients with Alzheimer's disease: focus on aripiprazole.
    Madhusoodanan S; Shah P
    Clin Interv Aging; 2008; 3(3):491-501. PubMed ID: 18982919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics in the management of behavioral symptoms associated with dementia.
    González-Concepción JJ; Geil K; Jiménez-Velázquez IZ; Ramos-Romey C
    Bol Asoc Med P R; 2009; 101(1):51-3. PubMed ID: 19954089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer's disease: focus on brexpiprazole and pimavanserin.
    Caraci F; Santagati M; Caruso G; Cannavò D; Leggio GM; Salomone S; Drago F
    F1000Res; 2020; 9():. PubMed ID: 32695312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavioural and psychological symptoms of dementia (BPSD): pharmacological management].
    Gillabert C; Desmeules J; Vogt-Ferrier N; Dayer P
    Rev Med Suisse; 2006 Apr; 2(61):970-5. PubMed ID: 16686329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy.
    Salzman C; Jeste DV; Meyer RE; Cohen-Mansfield J; Cummings J; Grossberg GT; Jarvik L; Kraemer HC; Lebowitz BD; Maslow K; Pollock BG; Raskind M; Schultz SK; Wang P; Zito JM; Zubenko GS
    J Clin Psychiatry; 2008 Jun; 69(6):889-98. PubMed ID: 18494535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease.
    Creese B; Da Silva MV; Johar I; Ballard C
    Expert Rev Neurother; 2018 Jun; 18(6):461-467. PubMed ID: 29764230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Judicious" use of neuroleptic drugs in the treatment of behavioral symptoms in the course of Alzheimer disease].
    Riva E; Nobili A; Trecate F
    Recenti Prog Med; 1998 Nov; 89(11):598-603. PubMed ID: 9844448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions.
    Ballard C; Corbett A; Chitramohan R; Aarsland D
    Curr Opin Psychiatry; 2009 Nov; 22(6):532-40. PubMed ID: 19696673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.
    Schneider LS; Tariot PN; Dagerman KS; Davis SM; Hsiao JK; Ismail MS; Lebowitz BD; Lyketsos CG; Ryan JM; Stroup TS; Sultzer DL; Weintraub D; Lieberman JA;
    N Engl J Med; 2006 Oct; 355(15):1525-38. PubMed ID: 17035647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of norepinephrine in the behavioral and psychological symptoms of dementia.
    Herrmann N; Lanctôt KL; Khan LR
    J Neuropsychiatry Clin Neurosci; 2004; 16(3):261-76. PubMed ID: 15377733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of behavioural and psychiatric symptoms in dementia: implications of recent safety warnings.
    Bullock R
    Curr Med Res Opin; 2005 Jan; 21(1):1-10. PubMed ID: 15881470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
    Lawlor BA
    J Clin Psychiatry; 2004; 65 Suppl 11():5-10. PubMed ID: 15264965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD).
    Gareri P; Cotroneo A; Lacava R; Seminara G; Marigliano N; Loiacono A; De Sarro G
    Arch Gerontol Geriatr Suppl; 2004; (9):207-15. PubMed ID: 15207416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atypical antipsychotics for elderly patients: to prescribe or to ban?].
    Rollini M; Schulz P
    Rev Med Suisse; 2008 Apr; 4(153):979-80, 982-4. PubMed ID: 18549086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole in the treatment of Alzheimer's disease.
    De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
    Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosis and antipsychotic medications in Alzheimer's disease: clinical management and research perspectives.
    Sultzer DL
    Dement Geriatr Cogn Disord; 2004; 17(1-2):78-90. PubMed ID: 14566100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.